
Press release: Ncardia and Cellistic recruit Gustavo Mahler to lead the businesses through their next phase of growth

Press release: Ncardia launches Cellistic, an iPSC cell therapy CDMO

Press release: Ncardia Appoints Andy Holt as Chief Commercial Officer

Press release: Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC Offerings

Press release: Cell & gene therapy accelerator to de-risk early stage research

Optimization of the Ncyte Astrocyte Kit